Introduction: Hydrolytic degradation is the most common cause of formation of impurities or degradation products in drugs during different stages of drug product development and/or shelf life of the drug/product. Degradation products formed by hydrolysis of ester, amide, urethane, sulfonamide, sulfonate and ether linkages, and of nitrile, hydroxyl and amino groups in drugs can be conveniently predicted and identified. Many drugs are known to degrade to such expected conventional hydrolytic degradation products, and the mechanisms of such degradations are also well known and reported. However, many drugs are reported to degrade under hydrolytic conditions to products, which cannot be justified by the conventional hydrolytic reactions. Objectives: Though structures of such unconventional hydrolytic products can be characterized through different spectral techniques, but there is a need to understand the mechanisms of such unconventional hydrolytic reactions in order to help in establishing intrinsic stability characteristics of a drug. Methodology: In the present review, we have studied and critically analysed all possible reports on hydrolytic degradation of various dugs to provide a thorough insight into unconventional routes of hydrolytic degradations of drugs. The various unconventional hydrolytic reactions found responsible for degradation of drugs are classified as oxidation, dehydrogenation, coupling/condensation, N-alkylation, C-C bond cleavage, C-N bond cleavage, dehalogenation, cyclization, decarboxylation and hydroxylation. Discussion: Varied types of reactions under hydrolytic conditions are triggered/controlled by the nature of substituent(s) across or around the susceptible bonds/groups. The mechanisms for such unconventional hydrolytic reactions have been discussed or proposed with support from the standard literature. The contents are expected to enable an analyst and a drug formulator to predict various possible as well as seemingly improbable hydrolytic degradation products of a drug well ahead of systematic forced degradation studies.
INTRODUCTION
With the enforcement of different guidelines issued by various international drugs regulatory authorities such as WHO, US-FDA, EMEA and ICH, the control of impurities in drugs has become an integral component of drug development process. [1] [2] [3] [4] Many guidelines issued by individual countries such as Therapeutic Product Directorate (Canada) and Therapeutic Goods Administration (Australia) also recommend that impurities should be controlled in the drug products. [5] [6] All these guidelines require, as a part of the registration dossier of the drug product, submission of complete data of any impurity that may be inherently present or formed by degradation at any stage of the drug and/or product development. The data includes information about identification, separation and structural characterization of the impurity. ICH guidelines have classified the impurities as organic, inorganic and residual sol-vents. 3, 4, 7, 8 These are also classified as process related impurities (PRIs) that are incorporated in a drug substance during the synthesis and purification processes, and degradation related impurities (DRIs) that originate during formulation development, transport and/or shelf life of the product. DRIs are also termed as degradation products or degradation impurities. These arise invariably due to chemical susceptibility of different functional groups (such as amide, ester, ether, nitrile, active methylenes, nitro and other groups) present in a drug substance to varied chemical environments (such as moisture, heat, light, pH modulating agents, taste modifiers, antioxidants, preservatives and air) to which the drug may be exposed at different stages of product development, storage and transport. During the normal course of formulation development, and shelf life, DRIs are formed usually in trace levels. Hence, their structural characterization becomes a challenging task. ICH guideline Q1A(R2) has recommended conduct of forced degradation studies or stress studies on drug substances under different chemical environments to facilitate identification of DRIs. 9 The purported aim of these studies is to generate all possible impurities that may form during shelf life of drug substance or product in a short span, and outline the degradation behaviour of the drug. These data will help in establishing intrinsic stability characteristics of the drug, developing and validating stability-indicating assay methods, and assisting a drug formulator in selection of excipients that discourage the formation of DRIs. Hydrolysis is one of the most common causes of degradation of drug substances. Almost every drug molecule contains one or more functional group or linkage, which is susceptible to hydrolysis. It is more common in drug substances formulated as liquid orals and injectables. Nonetheless, the probability of hydrolytic degradation is equal in solid dosage forms owing to presence of some essential moisture content. Moreover, many excipients such as taste modifiers, preservatives and antioxidants can modulate pH of the product, which can affect the rate and extent of hydrolytic degradation. Numerous research reports on degradation of different drugs under hydrolytic conditions are available in literature. Mabey and Mill 10 have reviewed hydrolytic behaviour of different classes of organic compounds under different chemical environments. Reviews of hydrolytic susceptibility of sulfonylureas, cellulose and polymers are also available in literature. [11] [12] [13] In the present review, we have analysed the available literature reports on degradation behaviour of drugs in order to understand their fate under hydrolytic conditions, irrespective of their chemical and therapeutic class. These reports are classified on the basis of types of chemical reactions that are reported to be responsible for degradation of the drugs. Broadly, these reactions are classified into two categories, i.e. conventional reactions such as hydrolysis of ester, amide, ether, and other linkages, and unconventional reactions such as oxidation, dehydrogenation, dehalogenation, decarboxylation, deamination, hydroxylation, cyclization, coupling, N-alkylation, C-C bond cleavage, reduction, and others. The mechanism(s) for any hydrolytic degradation, wherever reported, were reviewed. The mechanisms that seemed improbable or irrational at the outset were studied critically by referring to the literature of organic chemistry. Some of the reported mechanisms did not receive any literature support. For some of such cases, alternate mechanisms were proposed with appropriate support from the literature. The reported routes/mechanisms of drug degradation are shown by bold arrows whereas the alternately proposed routes, wherever possible, are represented by dotted arrows in the same Figure. This review can be helpful in predicting the hydrolytic susceptibility of any drug before the conduct of forced degradation study.
CONVENTIONAL HYDROLYTIC REACTIONS
The amide (carboxamide and sulfonamide), ester (carboxylic ester, phosphoester, thioate ester and sulfonate ester), sulfonylurea and/or ether linkages in a drug are readily hydrolyzed in aqueous environment. However, water alone is not usually sufficient to affect these degradations due to the poor leaving ability of -NH 2 , -NHR, -NR 2 and -OR groups. Addition of a trace amount of acid or alkali catalyzes this reaction significantly. The rate and extent of hydrolytic degradation depends invariably on pH of the medium (acidic, alkaline or neutral), exposure temperature and time, and nature of the other functional groups in the drug. Both amide and ester linkages are readily cleaved under hydrolytic conditions through bimolecular nucleophilic substitution (S N 2) mechanism.
14 Carboxamide and sulfonamide linkages have contrasting hydrolytic susceptibilities. While carboxamide is readily cleaved in alkaline medium, sulfonamide remains relatively stable. On the other hand, carboxamide remian stable in acidic medium but sulfonamide is readily hydrolyzed.
14 Nonetheless, not all sulfonamides are hydrolyzed in acidic medium. Sulfasalazine, a classical drug, is highly resistant to acidic hydrolysis. This exceptionally high stability of sulfasalazine is attributed to diazo group at para-position with respect to the sulfonyl group. This para orientation of the two groups causes electrons to delocalize and makes the sulfonyl sulfur resistant to nucleophilic attack by oxygen of water molecule (nucleophile). 15 The nature of substituents across the C-N, S-N or C-O bond also plays an important role in deciding hydrolytic susceptibility of these bonds. Sulfonylurea derived drugs and pesticides are highly susceptible to hydrolysis especially in acidic medium. 11 Glibenclamide, gliclazide, glimepiride and glipizide degrade to sulfonamide and an amine with the liberation of CO 2 . [16] [17] [18] [19] This degradation has been suggested to be initiated equally through O-protonation or N-protonation. 18 Drugs known to degrade due to amide and/ or ester linkages under different hydrolytic environments are given in Table 1 , and structures of some of these drugs, with cleavage sites indicated by dotted lines, are given in Figure 1(a)-1(c) . An ether linkage is usually hydrolyzed under vigorous conditions, such as concentrated acids and high temperatures, to an alkyl halide and an alcohol, or two molecules of alkyl halides through unimolecular and bimolecular nucleophilic substitution (S N 1 and S N 2) reactions. 88 Many drugs degrade through ethereal cleavage even in mild acidic medium at different temperatures. Ambrisentan, 89 azilsartan, 32 Figure 2 ). Baertschi and Alsante have very clearly outlined the pathway of degradation of duloxetine due to cleavage of ether linkage, 96 which is supported by Bansal et al to explain the similar degradation behaviour of toremifene. 95 Conversion of a nitrile group (C≡N) to carboxylic acid through addition-substitution mechanism is another conventional hydrolytic reaction, which is responsible for chemical conversion of anastrazole, 97 Figure 2 ). Polarization of C≡N bond attracts nucleophilic attack of H 2 O in alkaline medium to form an addition product, which tautomerizes to amide. The latter subsequently hydrolyzes to carboxylic acid depending on the type of substituent present. In case of alogliptin 101 and vilazodone, 82 reaction halts at the amide product. Lomustine 102 degrades to secondary amines with the loss of NO 2 under hydrolytic conditions ( Figure 2 ). Some drugs containing hydroxyl group such as desvenlafaxine 103 and pridinol 104 undergoes dehydration under acidic hydrolytic condition.
UNCONVENTIONAL HYDROLYTIC REACTIONS
Many drugs degrade under hydrolytic conditions to products, whose formation cannot be explained on the basis of conventional hydrolytic reactions as discussed above. Such degradation products, termed here as unconventional hydrolytic products, are reported to form by oxidation, dehydrogenation, dehalogenation, decarboxylation, deamination, hydroxylation, cyclization, coupling, N-alkylation, and other reactions as mentioned earlier. Mechanisms of formation of only a few of such unconventional hydrolytic drug degradation products are proposed and discussed in literature. The mechanisms of formation of other such products remain elusive or unexplored. In this section, we have critically analyzed all possible reports on unconventional hydrolytic products, classified those on the basis of type of reaction, and proposed or discussed the possible mechanisms, or dissented the reported proposed routes for formation of these products. Oxidation: Drugs belonging to chemical categories of amines, thioethers, sulfoxides and alcohols are well known to undergo oxidation under oxidative or photolytic conditions, and their mechanisms are well established.
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Some of such drugs are also reported to degrade through oxidation under hydrolytic conditions (Table 3 , Figure 3 ), but mechanisms of such oxidative degradations remain unknown. In fact, no report has attempted to propose any possible mechanism for such hydrolytic oxidations. N-, S-or C-oxidation usually occurs under the influence of oxygen (air or atmospheric oxidation) or other oxidizing agents such as potassium permanganate, potassium dichromate and hydrogen peroxide (chemical oxidation). Under hydrolytic conditions, when no chemical oxidizing agent is added, the only possible reason of oxidation remains the air, which is usually not flushed out from the reaction medium while carrying out forced degradation studies. Therefore, this oxygen from the air in the medium seems responsible for oxidation through different mechanisms. Degradation of dexamethasone and fesoterodine due to oxidation of hydroxymethylene group can be very conveniently explained on the basis of radical mediated mechanism. Similarly, degradation of benzopyridooxathiazepine by oxidation of methylene linker to carbonyl linker can be supported on the basis of a report wherein such products are reported to form in aqueous medium but through radicals. 106 Amines are also oxidized in air but through unknown radical mediated mechanisms. Now, the other perplexing question that may arise is that from where these radicals can originate in aqueous acidic or alkaline media? Usually during forced degradation studies in aqueous hydrolytic environment, dissolved oxygen and other gases are not removed with the help of nitrogen flushing. So, it may this dissolved oxygen that may generate some radicals from water and trigger these unconventional reactions. Continue... Base catalyzed ether hydrolysis: Cleavage of ether linkage in acidic medium is quite common and well documented, as discussed under conventional reactions. But certain drugs are reported to degrade by cleavage of ethereal linkage in alkaline medium also. Duloxetine degrades to 1-naphthol through the cleavage of aryl alkyl ether linkage in alkaline medium. 90 This degradation reaction may be mechanized as follows: Thiophene nucleus and naphthyloxy oxygen make the α-alkyl carbon electron deficient (Figure 4 ). It attracts nucleophilic attack of OH -and releases naphthyloxy ion (better leaving group), which is then converted into naphthol. Bosentan is another drug, which is reported to degrade due to the loss of 2-hydroxyethyl group through the cleavage of aryl alkyl ether linkage in acidic as well as alkaline media. 28 Here, it is proposed to occur as follows: In alkaline medium, hydroxyl group is ionized to form an oxide (a nucleophile), which subsequently attacks the α-carbon resulting in formation of oxirane and phenolic product (Figure 4 ). This proposition is based on the reactions for formation of oxiranes.
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Based on these proposed mechanisms of reactions, it can be hypothesized that an aryl alkyl ether linkage, in which α-carbon is electron deficient, may be hydrolyzed under alkaline condition also. Coupling/Condensation: Lomustine ( Figure 5 ) degrade under alkaline hydrolytic condition to a product, which is characterized as dimer. 102 However, no explanation or possible mechanism for such an extremely unusual reaction is mentioned. The normal expected course of reaction under hydrolytic condition is hydrolysis of lomustine to a carbamic acid intermediate (CAI), which is highly unstable, and is immediately hydrolyzed to cyclohexylamine. Formation of dicyclohexyl urea (a dimer product) may be justified through bimolecular nucleophilic substitution reaction between cyclohexylamine and CAI 1 or lomustine itself 2 ( Figure 5 ), wherein nucleophilic nitrogen of cyclohexylamine is attracted towards electrophilic carbonyl carbon of CAI or lomustine. PAC-I (Figure 1(b) ) is reported to degrade to a dimer product. 116 Formation of this degradation product is possible only if hydrazide N-N bond is cleaved. However, we have not found any support in literature where such a cleavage is reported to occur in hydrolytic environment. Degradation of idrocilamide to a dimer product (a linear conjugated anhydride) in both acidic and alkaline media 117 may be explained as shown in Figure 6 . The conventional hydrolysis of amide linkage in idrocilamide yields 3-phenylacrylic acid (3-PAA) and ethanolamine. In alkaline medium, 3-PAA exists as carboxylate ion whose nucleophilic oxygen can easily displace ethanolamine from the drug to form the dimer product. In acidic medium, generation of this product may be possible by an altogether different route as outlined. Olmesartan 64 is also reported to form a dimer product in acidic medium, which is an anhydride (Figure 6 ), similarly as in idrocilamide. The mechanism of formation of this product may be same as proposed for idrocilamde. N-alkylation: Amines are well known to react with alkyl halides to form the amines of higher class. It occurs through interaction between the lone pair of nitrogen atom (nucleophile) and the electron deficient α-carbon (electrophile) of alkyl halide. 105 The α-carbon in an alcohol is significantly weak electrophile than that of an alkyl halide due to inherent difference between electronegativities of -OH and halide groups. However, despite this weak electrophilicity, an alcohol may also cause alkylation of amino nitrogen in a drug, if reaction conditions are conducive. Esomeprazole is such an example, in which methylation occurs at nitrogen atom of benzimidazole nucleus of the drug under acidic hydrolytic condition. 109 This N-methylation can be attributed to methanol, which is used as a co-solvent during forced degradation study. Here, the intra-molecular H-bonding may trigger a series of electron movements that causes a nucleophilic attack of benzimidazole nitrogen at methyl group of methanol ( Figure 7) . The released OH -ion, being a poor leaving group, immediately accepts a proton from the cationic intermediate to form H 2 O. Candesartan cilexetil is another example, in which ethylation occurs at nitrogen atom of tetrazole ring under acidic and basic hydrolytic conditions. 118 Formation of this product may be justified by a mechanism that involves a nucleophilic attack of tetrazole nitrogen at methylene group of ethanol, which is generated by hydrolytic cleavage of ether linkage on benzimidazole ring (Figure 7) . C-C bond cleavage: Cleavage of C-C bond is very improbable under hydrolytic conditions. Fesoterodine in acidic medium 49 and voriconazole in alkaline medium 119 are reported to degrade through this unusual reaction. Degradation of voriconazole due to C-C bond cleavage may be mechanized as outlined in Figure 8 . In alkaline medium, benzylic hydroxyl group is ionized to an oxide that subsequently causes cleavage of C-C bond connecting phenyl and pyrimidine rings. This cleavage seems possible due to the pyrimidine ring that facilitates delocalization of electrons through resonance. Dehalogenation: Aryl halides are conventionally converted into substituted product by strong nucleophile or reduced product by reducing agents in photochemical conditions. 105 In gross exception to this, some drugs are reported to degrade to a substituted product, e.g. florfenicol 50 and ornidazole, 120 or to dehalogenated product, e.g. amlodipine 22 and atorvastatin 121 in acidic and/or alkaline hydrolytic condition (Figure 9 ). Justification for formation of such degradation products by dehalogenation reactions under hydrolytic conditions seems far away from the reality. Hydroxylation: Alkanes and cycloalkanes are readily oxidized to alcohols by aqueous H 2 O 2 in trifluoroacetic acid. 105 But hydroxylation of cycloalkanes under acidic as well as alkaline hydrolytic conditions as seen in case of dexamethasone 107 and simvastatin 122 is quite unusual reaction. A possible mechanism for this reaction of dexamethasone in acidic medium can be explained through involvement of keto-enol tautomerization, which attracts nucleophilic addition of OH -at C-6 and subsequently displaces the hydroxyl proton at C-3 ( Figure 10 ). Formation of this product in alkaline hydrolytic condition may be possible only through radical mediated mechanisms. In case of simvastatin, hydroxylation simply involves replacement of ethylenic hydrogens with OH -ions in alkaline medium ( Figure 10 ). Dehydration of carboxylic acids: A carboxylic acid readily undergoes dehydration under pyrolytic condition to form a ketene, which is stated to be an extremely reactive and unimportant functional group. 105 It reacts as "super anhydride", and gives carboxylic acid with water and an ester with an alcohol. This behaviour reflects that in aqueous medium, ketene is extremely less probable to exist in free form. Rather, it may exist in equilibrium with carboxylic acid. Oliveira et al. have reported lumiracoxib to degrade to a ketene (II) due to dehydration of -COOH group in acidic hydrolytic condition (Figure 11) . 123 However, existance of II is in gross disagreement with the exceptionally high reactive nature of ketene. Most likely, II formed due to dehydration can be converted back into lumiracoxib through hydration of the C=O bond 104 followed by tautomerism (Figure 11 ). Hence, it is possible that lumiracoxib might degrade through some other mechanism to form a stable product having a mass equal to that of II. Lumaricoxib molecule contains a dihalogenated anilino group. Presence of a fluorine and a chlorine (both highly electron withdrawing) at ortho positions makes the anilinic hydrogen highly acidic, which can facilitate intra-molecular H-transfer to generate a nitranion (III). The nucleophilic nitrogen in III readily attacks the electrophilic carboxylic carbon and releases H 2 O to form a lactam product, which has mass equal to that of II (Figure 11 ), and is also more stable than II. The correct structure can be conveniently allotted on the basis of fragment peaks in the mass spectral data of the product. C-N bond cleavage: Conversion of cytosine to uracil, and of guanine to xanthine are classical examples of deamination reactions (C-N bond cleavage) through enzymatic catalysis. 124, 125 However, such conversion under non-enzymatic hydrolytic environment is not well reported in standard literature. Despite it, many drugs are known to degrade to ketonic or other substituted products due to cleavage of C-N bond in both acidic as well as alkaline medium (Table 4) . Ketonic products are formed from drugs belonging to category of enamines in acidic as well as alkaline medium through mechanism proposed (Figure 12 ) as follows: Under acidic condition, protonation of enamine generates a quaternary amine, which makes the α-carbon an electrophilic centre. The latter attracts the nucleophilic attack by H 2 O to form an amino alcohol intermediate. Subsequently, under the influence of heat, C-N bond is cleaved to form ketonic product with the liberation of an amine and free acid. Under alkaline condition, OH -ion (a strong nucleophile) attacks directly at electron deficient α-carbon resulting in displacement of amine and formation of an enol, which is tautomerized to the ketonic product. In case of formation of substituted products, the reaction will stop at the isomerisation stage to produce unsaturated chloro product. Drugs having saturated amine groups degrade due to partial charge separation across the C-N bond owing to its polarity (Figure 12) . In acidic medium, this charge separation is exaggerated by protonation of amino nitrogen that attracts nucleophilic attack of H 2 O (weak nucleophile), whereas in alkaline medium, OH
-(a strong nucleophile) is attracted by the electron deficient α-carbon. The relative susceptibility of different amine drugs to C-N bond cleavage depends largely on the nature of leaving group, which in this case is an amine. The order of strength of leaving abilities of different amines is 3° > 2° > 1° > NH 3 > aromatic amines. In addition, any functional group that increases electrophilicity of α-carbon increases the leaving ability of the amino group. Cyclization: Under hydrolytic conditions, a C-O, C-N, C-S and C-X bond is cleaved through addition of a H 2 O molecule. In contrast to it, some drugs are reported to degrade under hydrolytic condition (Table 5) to cyclic products, and these products are possible to form only through dehydration assisted formation of lactam (C-N) or lactonic (C-O) linkages. Tenatoprazole degrades to an indene derivative (IV) under both acid and alkali hydrolytic conditions. A mechanism of formation of this product in acid hydrolysis is also outlined (Figure 13 ), wherein it is reported that "under acidic conditions, the pyridinyl nitrogen is protonated to form pyridinium. Then the lone pair of electrons on the pyridinyl nitrogen undergoes nucleophilic attack at the electron deficient carbon (2nd carbon) of the imidazole ring. This results in the formation of indene derivative of tenatoprazole". 143 A careful analysis of this outlined mechanism reveals that this proposition is self contradictory because of two observations. Firstly, protonation of pyridinyl nitrogen will use up its lone pair of electrons, and hence these are not available for nucleophilic attack on C-2 of imidazole. Secondly, the product is detected at m/z 298 in +ESI mode suggesting it to contain an odd number of nitrogen atoms. 144 But the reported structure of the degradation product contains an even number (four) of nitrogen atoms. Based on these observations, it may be understood that structure of the product as proposed in the report is not correct. Ritonavir is reported to degrade through hydrolytic cleavage of urethane linkage to form thiazol-5-yl methanol (V), and a carbamic acid product (VI) under alkaline hydrolytic condition. The latter subsequently loses H 2 O to form an oxazolidinone product (a cyclized degradation product, VII) (Figure 14) . 72 This route seems less probable given to the fact that a carbamic acid is highly unstable, which under hydrolytic conditions readily tends to lose CO 2 to form an amine (VIII). Incidentally, VIII is not reported to be detected in the study. Contrary to this reported route, the same product (VIII) can be conveniently formed through another single step route that involves nucleophilic attack of alkoxy oxygen onto carbonyl carbon of urethane linkage resulting in the release of 5-oxathiazolylmethoxide (IX) as leaving group (Figure 14) . On the similar note, darunavir is reported to degrade through hydrolytic cleavage of carbamate linkage to form a carboxylic acid (X) under alkaline condition that subsequently undergoes dehydration to form an oxazolidinone product (XI). 36 But here again, the formation of the product can be explained by the alternate mechanism as proposed for degradation of ritonavir to product VII ( Figure 15 ). Toporisic et al. have reported that enalapril degrade to a piperidinone-pyrrolidine fused product (XII) at 100 °C involving the formation of an amide bond. 42 However, this route of formation of XII seems to be less probable because formation of an amide bond in alkaline medium at such a high temperature is neither reported nor supported in literature. It reveals that enalapril might have degraded to some other product having mass same as that of XII. A concentrated look into structure of enalapril reveals that there are three active hydrogens, [1] [2] [3] that can generate carbanions (XIII-XV, respectively) in the presence of a base ( Figure 16 ). The carbanionic centers can attack the electrophilic centers (carbonyl carbon or α-carbon) intra-molecularly resulting in three possible products (XVI-XVIII, respectively). Product XVI, though is formed in a single step, seems less probable because of generation of strained fused heterocyclic system bearing -COOH group at bridge carbon of the fused system. The other two products, XVII and XVIII, seem more stable than XVI as well as XII. Hence, the exact structure to the degradation product detected in the study can be assigned through mass fragmentation/spectral data. Ezetimibe is found to degrade through rearrangement of β-lactam ring to tetrahydropyrane ring in basic medium ( Figure 17) . 142 There are two shortcomings in proposition of the structure through this rearrangement. Firstly, an aliphatic C-N bond is cleaved while a β-lactam amide bond remains intact, which is much more susceptible to hydrolysis than the C-N bond. Secondly, no mass fragmentation or spectral data is given in support of formation of this product. So, herein, we propose that under hydrolytic conditions, the β-lactam ring opens due to hydrolysis of the amide bond (which is highly susceptible in alkaline medium as per the standard literature) to form a carboxylic acid intermediate (XIX) . It exits as carboxylate in alkaline medium, and its nucelophilic oxygen displaces the -OH group to form a lactonic product (XX), which is stable than the β-lactam drug itself in alkaline medium. Diclofenac, flupirtine and quinapril degrade to cyclized products, and formation of these products are reported to occur through formation of an amide bond between a carboxylic acid and an amino group in acidic medium ( Figure 18) . 141, 51, 71 However, these routes seem improbable because the amino group is protonated in acidic medium destroying the nucleophilic character of amino nitrogen. Moreover, in diclofenac, presence of two chloro groups ortho to the -NH-group further intensifies the electron deficiency on the nitrogen. Hence, there is a need to study the products of these drugs to propose their unambiguous structures. Indinavir degrades in acid hydrolytic condition through hydrolysis of an amide bond followed by condensation between the -OH and the free -COOH groups ( Figure  19 ). 53 This product is possible only if hydrolysis of amide bond 2 occurs in prefence over amide bond 1. The valid reasons to support this reported route are, (i) the amide bond 2 is sterically hindered in comparison to amide bond 1, and (ii) the i-butyl group in amide bond 1 makes the amide nitrogen less electron deficient that in turn decreases the electrophilicity of carbonyl carbon in the bond. Tamsulosin is reported to degrade by a mechanism that involves abstraction of acidic proton from sulphonamide by -OH resulting in formation of anion that attacks ether containing phenyl carbon resulting in the release of methanol to form a four membered ring ( Figure  20 ).
138
Reactions at active methylene group: A methylene group is said to be "active", when it is flanked by two strong electron withdrawing groups and/or elements. The carbon atom of such a methylene group is electron deficient, and the hydrogens attached to it become acidic. Ropinirole under alkaline condition form a hydrolyzed product due to the reactivity of active methylene group in the drug molecule through the mechanism as given in Figure 21 . 75 The product XXI is formed by the attack of OH -at active methylene carbon resulting in cleavage of γ-lactam ring followed by loss of carbon monoxide. Ornidazole is converted into an oxirane product under alkaline hydrolytic condition due to the reactivity of active methylene group. 120 The most plausible mechanism for this reaction is outlined in Figure 22 . Dehydrogenation: It is one of the most unusual reactions that can occur in a hydrolytic medium. Benzopyridooxathiazepine is reported to degrade under acidic hydrolytic condition to a dehydrogenated product (XXII) by a mechanism that involves N-protonation followed by rapid dehydrogenation that leads to the formation of corresponding iminium that further reacts by Michael addition of H 2 O followed by dehydration. 26 However, formation of imimiun by this route seems improbable because of the following reasons: In the first step, the pyridine nitrogen is quaternized by protonation, which is accepted to occur in the acidic medium. But subsequently, H 2 O molecule is shown to abstract the α-proton triggering electronic movements leading to loss of proton from the quaternized nitrogen, which is accepted by Cl -. Now, here water is a weak base and the α-methylene is very weak acid. The spontaneity of reaction between such a weak acid and weak base is very less. Secondly, Cl -is a weak conjugate base of HCl (strong acid) and therefore its propensity to accept a proton to form HCl again is very remote. Thus, an alternate route of degradation of benzopyridooxathiazepine is proposed (Figure 23 ), on the basis of explanation by Baertschi and Alsante 14 for a similar degradation, that involves oxidation of tertiary nitrogen to N-oxide (oxidation of tertiary amines is well reported and already discussed in preceding section), followed by protonation in acidic medium to form hydroxylamine. The latter undergoes dehydration to form iminium, which subsequently loses proton to form XXII. Darifenacin is reported to degrade to a dehydrogenated product XXIII by dehydrogenation in furan ring ( Figure 23 ) 35 Though tetrahydrofuran or dihydrofuran does undergo air oxidation to furan but in the present case, the dehydrogenation from the dihyrofuran ring seems less probable because of presence of tertiary nitrogen in the form of pyrollidine. Nitrogen being a better nucleophile than oxygen, tends to undergo protonation as well as oxidation preferentially. Thus, the degradation of darifenacin can be proposed to occur by dehydrogenation that involves nitrogen atom by a similar mechanism as proposed for benzopyridooxathiazepine to form a dehydrogenated product XXIV (Figure 23 ). Both XXIII and XXIV have the same accurate molecular mass, and the actual structure can be ascertained through mass fragmentation data. Reduction of carboxylic acid: This reaction is exactly opposite to dehydrogenation, which is discussed just in the preceeding section. A carboxylic acid is known to reduce to a primary alcohol in the presence of reducing agents. However, zofenopril is reported to reduce under alkaline hydrolytic condition (Figure 24) . 85 For this, neither any mechanism is proposed in the report nor there any literature support. Hence, there is a need to analyze, and probably revise, the proposed route for formation of this product from zofenopril. Decarboxylation: An electron withdrawing group at α-/β-position or α,β-conjugated double bond in some aliphatic carboxylic acids makes them susceptible to decarboxylation either by S E 1 or S E 2 mechanism. 105 Ambrisentan is reported to undergo decarboxylation in acidic hydrolytic medium 89 by the mechanism as outlined in Figure 25 . Protonation of the carboxylic acid of ambrisentan in acidic medium makes the carbonyl carbon a strong electrophile. It attracts nucleophilic attack of oxygen of the adjacent methoxy group resulting in formation of the product with the release of methanol and carbon dioxide. Ketorolac is reported to degrade by a mechanism (Figure 25) , that involves the abstraction of proton from water molecule by carbonyl oxygen of carboxylic acid in acidic medium followed by dehydration and removal of formic acid 145 However, from a chemist's viewpoint, this reaction is not feasible as the probability of abstraction of proton from acid is more than from water molecule. Thus, an alternate mechanism may be involved that involves the protonation of carbonyl oxygen in acidic medium followed by release of a proton and formic acid ( Figure 25 ). Ring opening: Heterocyclic rings in many drugs are opened under hydrolytic conditions resulting in degradation of drugs. Isoxazole undergoes dehydration under alkaline condition to generate a cyano-enol product that tautomerizes to a more stable cyano-keto product. 146 This type of reaction has been reported in degradation of leflunomide ( Figure 26) . 147 In ampicillin (148) and flucloxacillin, 149 the bicyclic ring (β-lactam ring fused with thiazolidine ring) is highly unstable and cleaves to form an acyclic structure under alkaline condition. The mechanism involves the attack of OH -ions at carbonyl carbon of β-lactam ring to form a germinal diol intermediate that collapses by losing CO 2 to yield an intermediate (XXV). The latter is attacked by OH -ions at electron deficient carbon (carbon flanked by -NHand -S-groups) resulting in the cleavage of C-S bond of ring B (Figure 27 ).
CONCLUSIONS
Degradation of a drug under hydrolytic conditions is largely influenced by the nature of functional groups across or around the susceptible bonds or functional groups in the drug molecule. In addition to the conventional reactions such as hydrolysis of amide, ester, ether, urethane and anhydride linkages, and of nitrile group, some unusual reactions also occur in a drug molecule under hydrolytic conditions. Such unusual/unconventional hydrolytic reactions are not reported well in literature. Only some of the reports on hydrolytic degradation studies on drugs have attempted to outline mechanisms for some of such unconventional hydrolytic reactions. A critical analysis of available reports has revealed that some degradation products are characterized and proposed to form through a route which does not seem probable. With a chemist's viewpoint that a product cannot be more unstable than the reactant under a given reaction conditions, the most probable mechanisms/routes for formations of unconventional hydrolytic products are proposed and discussed as well as alternate but more probable and justifiable structures of some seemingly unjustified unconventional hydrolytic products are proposed. These data are compiled and discussed to assist an analyst to predict all possible (conventional/unconventional) degradation products/impurities that may form from drug in hydrolytic conditions during the forced degradation studies.
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